Skip to main content
. 2021 May 31;12:609771. doi: 10.3389/fendo.2021.609771

Table 2.

Cycle characteristics of the participants.

Ultra-long GnRH-a protocol (n=237) Long GnRH-a protocol (n=134) p value
Total dose of gonadotropin (IU) 2629.00 ± 858.77 2630.40 ± 913.95 0.988
Duration of stimulation (d) 11.29 ± 2.81 11.31 ± 2.78 0.95
Endometrial thickness in HCG day (mm) 10.82 ± 2.85 10.95 ± 3.00 0.678
Peak E2 (pmol/L) 8639.18 ± 5180.09 10039.03 ± 6883.23 0.01
No. of oocytes retrieved per cycle 8.31 ± 5.42  9.93 ± 7.04 0.004
No. of embryos available per cycle 3.89 ± 2.87  4.34 ± 3.16 0.17
No. of high-quality embryos per cycle 1.56 ± 1.97  1.61 ± 1.73 0.788
High-quality embryos transferred, n (%) 181/389 (46.5) 73/162 (45.1) 0.753
No. of embryos transferred per cycle 2.05 ± 0.57  2.05 ± 0.55 0.965
Stage at ET, n (%) 0.491
 Day 3 176/190 (92.6) 75/79 (94.9)
 Day 5 14/190 (7.4) 4/79 (5.1)
Type of ART, n (%) 0.850
 IVF 191/233 (82.0) 101/127 (79.5)
 ICSI 32/233 (13.7) 20/127 (15.7)
 IVF+ICSI 10/233 (4.3) 6/127 (4.7)
Moderate OHSS (n, %) 3 (1.3) 2 (1.5) 1.000
Cancellation of fresh ET, n (%) 47 (19.8) 55 (41.0) 0.000

Data are presented as mean ± SD or number (%).

ART, assisted reproductive technology; ET, embryos transferred.

IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection.